Vaccine Design: A Statisticans Overview

Similar documents
Vaccine Design: A Statisticans Overview

The Major Histocompatibility Complex (MHC)

VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.

1. Overview of Adaptive Immunity

By:Reham Alahmadi NOV The production of antibodies and vaccination technology

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Gene Vaccine Dr. Sina Soleimani

Trends in vaccinology

Profiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009

White Blood Cells (WBCs)

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

RAISON D ETRE OF THE IMMUNE SYSTEM:

Lines of Defense. Immunology, Immune Response, and Immunological Testing. Immunology Terminology

BBS 2711 Virology. Virus Vaccines

Adaptive Immune Response Day 2. The Adaptive Immune Response

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Adaptive Immunity: Specific Defenses of the Host

IMMUNOINFORMATICS: Bioinformatics Challenges in Immunology

A HLA-DRB supertype chart with potential overlapping peptide binding function

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

RAISON D ETRE OF THE IMMUNE SYSTEM:

Antigen Presentation to T lymphocytes

Immunology Lecture 4. Clinical Relevance of the Immune System

Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs.

Immunization (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

Vaccines and other immunological antimicrobial therapy 1

Lecture 11. Immunology and disease: parasite antigenic diversity

In other words. how to prevent David from killing Goliath. Tammy Rickabaugh, Ph.D. January 14, 2014

Antigen processing and presentation. Monika Raulf

Chapter 35 Active Reading Guide The Immune System

Chapter 22: The Lymphatic System and Immunity

Physiology Unit 3. ADAPTIVE IMMUNITY The Specific Immune Response

Principles of Adaptive Immunity

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Introduction to Immunology Part 2 September 30, Dan Stetson

Immunodeficiency. (2 of 2)

The World Health Organization (WHO) estimate that vaccination averts 2-3 million deaths per year (in all age groups), and up to 1.

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.

Glossary of Terms - Vaccinology 101 Nurse TIP Webcast

Stainless-steel vs Single-use: The Vaccines Perspective

M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

M I C R O B I O L O G Y

Page 4: Antigens: Self-Antigens The body has a vast number of its own antigens called self-antigens. These normally do not trigger immune responses.

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

chapter 17: specific/adaptable defenses of the host: the immune response

CHAPTER 18: Immune System

Vaccination. Artificially induced specific adaptive immunity

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Adaptive immune responses: T cell-mediated immunity

Structure and Function of Antigen Recognition Molecules

The Adaptive Immune Responses

Third line of Defense

Adaptive (acquired) immunity. Professor Peter Delves University College London

HLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

Alessandra Franco MD PhD UCSD School of Medicine Department of Pediatrics Division of Allergy Immunology and Rheumatology

A general overview of Immune system and. Shuyan Li 2/4/2009

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

Chapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally!

CONVENTIONAL VACCINE DEVELOPMENT

Transplantation. Immunology Unit College of Medicine King Saud University

Two categories of immune response. immune response. infection. (adaptive) Later immune response. immune response

Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Vaccines. Vaccines ( continued 1) February 21, 2017 Department of Public Health Sciences

Practical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen

Cellular Pathology of immunological disorders

The Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity

Basel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva

Overview: The immune responses of animals can be divided into innate immunity and acquired immunity.

Antigens and Immunogens

How HIV Causes Disease Prof. Bruce D. Walker

Antigen capture and presentation to T lymphocytes

9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018

Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Viral Genetics. BIT 220 Chapter 16

Introduction to Immune System

Annex 1. WHO Recommendations, Guidelines and other documents related to the manufacture and quality control of biological substances used in medicine

MHC class I MHC class II Structure of MHC antigens:

Major Histocompatibility Complex (MHC) and T Cell Receptors

Mucosal Immune System

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

TCR, MHC and coreceptors

HACKING HIV: CREATING AND ASSESSING A NOVEL CTL-BASED HIV-1 VACCINE

Overview. Barriers help animals defend against many dangerous pathogens they encounter.

There are 2 major lines of defense: Non-specific (Innate Immunity) and. Specific. (Adaptive Immunity) Photo of macrophage cell

Definition of MHC supertypes through clustering of MHC peptide binding repertoires

Immunobiology. Readiness Exam. Immune Response (two phases)

Adaptive Immunity: Humoral Immune Responses

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

Development of B and T lymphocytes

FOCiS. Lecture outline. The immunological equilibrium: balancing lymphocyte activation and control. Immunological tolerance and immune regulation -- 1

Chapter 17B: Adaptive Immunity Part II

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

Transcription:

GoBack

: A Statisticans Overview. Surajit Ray sray@samsi.info Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #1

The Chinese are credited with making the observation that deliberately infecting people with mild forms of smallpox could prevent infection with more deadly forms and provide life long protection. Introduction of first generation of vaccines for use in humans 1798 Smallpox 1926 Pertussis 1885 Rabies 1927 Tuberculosis (BCG) 1897 Plague 1923 Diphtheria 1927 Tetanus 1935 Yellow Fever Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #2

Live attenuated vaccines Inactivated or killed vaccines Recombinant sub-unit envelope vaccines Recombinant vectored vaccines DNA vaccines and replicons Involve HIV genetic sequences which, once injected, induce expression of HIV antigens by human cells. In the case of replicons, these sequences are wrapped in the outer coat of an unrelated virus. Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #3

Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #4

Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #5

Sequence Analysis Viral/Microbial Evolution. Being Lower forms of life ( or even unicellular organism) they can mutate much easily. But we cannot. Gene Expression Analysis Which Genes/Molecules/Protiens are expressed at certain time point in the viral life cycle. Classification and Prediction Which of these proteins will bind to the MHC Molecule present in a particular human being. Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #6

Destruction of infected cells and tumor cells by cytotoxic T-lymphocytes or CTLs. CTLs are effector cells derived from T8-lymphocytes during cell-mediated immunity. The TCRs and CD8 on the surface of naive T8-lymphocytes are designed to recognize peptide epitopes bound to MHC-I on antigen-presenting cells (APCs). Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #7

Major Histo Compatibility, also known as human leukocyte antigens or HLA Present on various human cells e.g. dendritic cells. Typically epitopes of length 9. MHC I animation MHC I movie 1 Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #8

Mechanism different from MHC I. More complicated as the binding length may be more than 9. MHC II animation MHC II movie 2 Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #9

Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #10

>A85A_MYCTU 48 GLPVEYLQV MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGAFSRPGLPVEYLQVPSPS MGRDIKVQFQSGGANSPALYLLDGLRAQDDFSGWDINTPAFEWYDQSGLSVVMPVGGQSS FYSDWYQPACGKAGCQTYKWETFLTSELPGWLQANRHVKPTGSAVVGLSMAASSALTLAI YHPQQFVYAGAMSGLLDPSQAMGPTLIGLAMGDAGGYKASDMWGPKEDPAWQRNDPLLNV GKLIANNTRVWVYCGNGKPSDLGGNNLPAKFLEGFVRTSNIKFQDAYNAGGGHNGVFDFP DSGTHSWEYWGAQLNAMKPDLQRALGATPNTGPAPQGA >A85A_MYCTU 242 KLIANNTRV MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGAFSRPGLPVEYLQVPSPS MGRDIKVQFQSGGANSPALYLLDGLRAQDDFSGWDINTPAFEWYDQSGLSVVMPVGGQSS FYSDWYQPACGKAGCQTYKWETFLTSELPGWLQANRHVKPTGSAVVGLSMAASSALTLAI YHPQQFVYAGAMSGLLDPSQAMGPTLIGLAMGDAGGYKASDMWGPKEDPAWQRNDPLLNV GKLIANNTRVWVYCGNGKPSDLGGNNLPAKFLEGFVRTSNIKFQDAYNAGGGHNGVFDFP DSGTHSWEYWGAQLNAMKPDLQRALGATPNTGPAPQGA >A85B_MYCTU 239 KLVANNTRL MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGAFSRPGLPVEYLQVPSPSMGR DIKVQFQSGGNNSPAVYLLDGLRAQDDYNGWDINTPAFEWYYQSGLSIVMPVGGQSSFYS DWYSPACGKAGCQTYKWETFLTSELPQWLSANRAVKPTGSAAIGLSMAGSSAMILAAYHP QQFIYAGSLSALLDPSQGMGPSLIGLAMGDAGGYKAADMWGPSSDPAWERNDPTQQIPKL VANNTRLWVYCGNGTPNELGGANIPAEFLENFVRSSNLKFQDAYNAAGGHNAVFNFPPNG THSWEYWGAQLNAMKGDLQSSLGAG >ACTB_HUMAN 180 ALPHAILRL MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS KRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT QIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDL AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSY ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLS GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQ EYDESGPSIVHRKCF Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #11

MHC class I genes (HLA-A, HLA-B and HLA-C) MHC class II genes (HLA-DP, HLA-DQ and HLA-DR) Database ALPHAILRL Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #12

We want to classify the peptides into Binders and non Binders. Binders of specific HLA-super types. Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #13

A supermotif is a motif which confers the ability to bind to several different HLA A supertype, the corresponding assembly of HLA As of October 2001, nine major HLA class I supertypes have been defined HLA-A1, A2, A3, A24 HLA-B7, B27, B44, B58, B62 e.g the 5 alleles belonging to HLA-A3 supertype: A*0301 A*1101 A*3101 A*3301 A*6801. Sette et al, Immunogenetics (1999) 50:201-212 Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #14

Mostly +ve examples. No good database of -ve examples. Include structural information of peptides in the classifier. In case of we do not know the position of binding. Supertypes are still being defined. Work in Progress... Slides produced with HA-prosper latex package Surajit Ray Samsi PostDoc Seminar: Nov 2: 2004 - slide #15